Checkout
Cart: £0.00 - (0 items )

Orchid Labs is in the process of raising $125 million for its surveillance-free layer atop the internet

Orchid Labs is in the process of raising 5 million for its surveillance-free layer atop the internet Orchid Labs, a San Francisco-based startup that’s developing a a surveillance-free layer on top of the internet, has raised a bunch of funding, according to a newly processed SEC filing that shows the year-old startup has closed on $36.1 […]

Read More

In the world of VC, harassment claims aren’t necessarily a deal killer

In the world of VC, harassment claims aren’t necessarily a deal killer  Silicon Valley has hardly been immune. In the world of venture capital, two of the highest-profile poster boys for this uprising (as of this writing) are venture capitalists Steve Jurvetson, formerly of the venture firm DFJ, and Shervin Pishevar, who cofounded the firm […]

Read More

VC Steve Jurvetson is leaving Draper Fisher Jurvetson

VC Steve Jurvetson is leaving Draper Fisher Jurvetson  Steve Jurvetson, the venture capitalist who invested in companies like Tesla and SpaceX, is leaving his role as partner at Draper Fisher Jurvetson, Recode reports. TechCrunch has since confirmed the news. “I am leaving DFJ to focus on personal matters, including taking legal action against those whose […]

Read More

The women of DFJ push back on claims that “predatory behavior” is rampant

The women of DFJ push back on claims that “predatory behavior” is rampant  Several women who either work at venture firm DFJ or have worked for the 30-year-old outfit in the past are pushing back against new allegations that founders should be wary of approaching the firm owing to “predatory behavior” that is “rampant.” Yesterday, […]

Read More

GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market

GE and the Mayo Clinic back software to bring cancer-fighting gene therapies to market  While $5.7 billion was invested in companies developing cellular and genetic therapies, and with 800 clinical trials initiated worldwide and the first two CAR-T cell therapies expected to launch into market later this year, businesses still say the ability to get these […]

Read More

Back to top